Adenosine Receptors and the Central Nervous System
The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–331 of 331
Blum, D., Gall, D., Galas, M., d’Alcantara, P., Bantubungi, K., & Schiffmann, S. N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09122.2002 · Cited by 82
Prediger, R. D., Batista, L. C., & Takahashi, R. N. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.106 · Cited by 82
Adenosine agonists CGS 21680 and NECA inhibit the initiation of cocaine self-administration
Knapp, C. M., Foye, M. M., Cottam, N., Ciraulo, D. A., & Kornetsky, C. H. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00486-5 · Cited by 82
Adenosine A 1 receptors modulate anxiety in CD1 mice
Florio, C., Prezioso, A., Papaioannou, A., & Vertua, R. (1998) · Psychopharmacology · doi:10.1007/s002130050572 · Cited by 82
The Lack of A2A Adenosine Receptors Diminishes the Reinforcing Efficacy of Cocaine
Sòria, G., Castañé, A., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300876 · Cited by 81
Díaz-Cabiale, Z., Hurd, Y. L., Guidolin, D., Finnman, U.-B., Zoli, M., Agnati, L. F., Vanderhaeghen, J., Fuxé, K., & Ferr�, S. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00014 · Cited by 81
Mishina, M., Ishiwata, K., Kimura, Y., Naganawa, M., Oda, K., Kobayashi, S., Katayama, Y., & Ishii, K. (2007) · Synapse · doi:10.1002/syn.20423 · Cited by 81
Yao, L., Fan, P., Jiang, Z., Mailliard, W. S., Gordon, A. S., & Diamond, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336093100 · Cited by 81
Stevens, B., Ishibashi, T., Chen, J., & Fields, R. D. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x04000055 · Cited by 81
Improved spatial recognition memory in mice lacking adenosine A2A receptors
Wang, J. H., Yuan, Y., & van den Buuse, M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.005 · Cited by 80
Deep Brain Stimulation for Psychiatric Disorders
Larson, P. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.11.006 · Cited by 80
Cunha, R. A., Sebastião, A. M., & Ribeiro, J. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09420.x · Cited by 78
Self-citationTheophylline Improves Esophageal Chest Pain?A Randomized, Placebo-Controlled Study
Rao, S. S. C., Mudipalli, R. S., Remes-Troche, J. M., Utech, C. L., & Zimmerman, B. M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01112.x · Cited by 78
Adams, C. L., Cowen, M. S., Short, J. L., & Lawrence, A. J. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007845 · Cited by 78
Ulugöl, A., Karadağ, Ç. H., Tamer, M., Firat, Z., Aslantaş, A., & Dökmeci, İ. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00491-3 · Cited by 77
Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans
Meyer, P. T., Elmenhorst, D., Boy, C., Winz, O., Matusch, A., Zilles, K., & Bauer, A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.005 · Cited by 77
Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro
O'Kane, E. M., & Stone, T. W. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00730-4 · Cited by 77
Clinical application of adenosine and ATP for pain control
Hayashida, M., Fukuda, K., & Fukunaga, A. F. (2005) · Journal of Anesthesia · doi:10.1007/s00540-005-0310-8 · Cited by 76
Limberger, N., Sp�th, L., & Starke, K. (1988) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168812 · Cited by 76
Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2Aand A2Badenosine receptors
Conde, S. V., Obeso, A., Vicario, I., Rigual, R. J., Rocher, A., & González, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03912.x · Cited by 75
Gauda, E. B., Northington, F. J., Linden, J. M., & Rosin, D. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02314-3 · Cited by 75
Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC
Soria, G., Castañé, A., Berrendero, F., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03682.x · Cited by 74
Corsi, C., Melani, A., Bianchi, L., & Pedata, F. (2000) · NeuroReport · doi:10.1097/00001756-200008030-00048 · Cited by 73
Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus
Coelho, J. E., Rebola, N., Fragata, I., Ribeiro, J. A., de Mendonça, A., & Cunha, R. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.012 · Cited by 71
Self-citationCaffeinated beverages and decreased seizure control
Kaufman, K. R., & Sachdeo, R. C. (2003) · Seizure · doi:10.1016/s1059-1311(03)00048-7 · Cited by 71
Correia‐de‐Sá, P., & Ribeiro, J. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90793-5 · Cited by 70
Self-citationFerreira, J. M., & Paes‐de‐Carvalho, R. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02279-x · Cited by 70
Angelatou, F., Pagonopoulou, O., Maraziotis, T., et al. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90217-9 · Cited by 69
Esser, M. J., Chase, T. D., Allen, G. V., & Sawynok, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01276-6 · Cited by 68
Functional genomics approach to hypoxia signaling
Seta, K. A., & Millhorn, D. E. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00836.2003 · Cited by 68
Toda, S., Alguacil, L. F., & Kalivas, P. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02121.x · Cited by 68
Decreased Presynaptic Sensitivity to Adenosine after Cocaine Withdrawal
Manzoni, O. J., Pujalte, D., Williams, J. T., & Bockaert, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07996.1998 · Cited by 67
Adaptations in Adenosine Signaling in Drug Dependence: Therapeutic Implications
Hack, S. P., & Christie, M. J. (2004) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v15.i34.30 · Cited by 66
Di Iorio, P., Battaglia, G., Ciccarelli, R., Ballerini, P., Giuliani, P., Poli, A., Nicoletti, F., & Caciagli, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010302.x · Cited by 66
Biber, K. P. H., Lubrich, B., Fiebich, B. L., Boddeke, H. W., & van Calker, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00169-x · Cited by 66
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Costentin, J., & Vaugeois, J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.007 · Cited by 65
Cunha, R. A., Ribeiro, J. A., & Sebastião, A. M. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00245.x · Cited by 64
Self-citationDomenici, M. R., Scattoni, M. L., Martire, A., Lastoria, G., Potenza, R. L., Borioni, A., Venerosi, A., Calamandrei, G., & Popoli, P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.009 · Cited by 64
Thorsell, A., Johnson, J., & Heilig, M. A. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00425.x · Cited by 64
Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus
Sperlágh, B., Zsilla, G., Baranyi, M., Illés, P., & Vizi, E. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.035 · Cited by 63
Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors
Pousinha, P. A., Diógenes, M. J., Ribeiro, J. A., & Sebastião, A. M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.036 · Cited by 62
Self-citationAbbracchio, M. P., Fogliatto, G., Paoletti, A. M., Rovati, G. E., & Cattabeni, F. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90010-s · Cited by 61
Effects of caffeine on the freezing of gait in Parkinson's disease
Kitagawa, M., Houzen, H., & Tashiro, K. (2007) · Movement Disorders · doi:10.1002/mds.21208 · Cited by 61
Carruthers, A. M., Sellers, L. A., Jenkins, D. W., Jarvie, E. M., Feniuk, W., & Humphrey, P. P. A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1533 · Cited by 61
Association study of A2a adenosine receptor genetic polymorphism in panic disorder
Lam, P., Hong, C., & Tsai, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.012 · Cited by 60
Godfrey, L., Yan, L., Clarke, G. D., Ledent, C. A., Kitchen, I., & Hourani, S. M. O. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.004 · Cited by 60
Ogata, T., Nakamura, Y., Tsuji, K., Shibata, T., Kataoka, K., & Schubert, P. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90225-9 · Cited by 59
Up-regulation of striatal adenosine A2A receptors in schizophrenia
Deckert, J., Brenner, M., Durany, N., Z??chling, R., Paulus, W., Ransmayr, G., Tatschner, T., Danielczyk, W., Jellinger, K., & Riederer, P. (2003) · NeuroReport · doi:10.1097/00001756-200303030-00003 · Cited by 58
Effect of adenosine on isolated and superfused cat carotid body activity
Runold, M., Cherniack, N. S., & Prabhakar, N. R. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90504-3 · Cited by 58
Ishiwata, K., Mishina, M., Kimura, Y., Oda, K., Sasaki, T., & Ishii, K. (2004) · Synapse · doi:10.1002/syn.20099 · Cited by 58
Kaster, M. P., Budni, J., Santos, A. R. S., & Rodrigues, A. L. S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.026 · Cited by 58
Gene expression and function of adenosine A2Areceptor in the rat carotid body
Kobayashi, S., Conforti, L., & Millhorn, D. E. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.2.l273 · Cited by 58
Florán, B., Rangel‐Barajas, C., Florán, L., Erlij, D., & Aceves, J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00479-7 · Cited by 57
Hussey, M. J., Clarke, G. D., Ledent, C. A., Hourani, S. M. O., & Kitchen, I. (2006) · Pain · doi:10.1016/j.pain.2006.10.014 · Cited by 57
Gu, J. G., Foga, I. O., Parkinson, F. E., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052105.x · Cited by 57
Almeida, T., Rodrigues, R. J., de Mendonça, A., Ribeiro, J. A., & Cunha, R. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00523-2 · Cited by 55
Self-citationToms, N. J., & Roberts, P. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00090-8 · Cited by 55
Adenosine-Based Cell Therapy Approaches for Pharmacoresistant Epilepsies
Boison, D. (2007) · Neurodegenerative Diseases · doi:10.1159/000100356 · Cited by 55
Adenosine receptor antagonists alter the stability of human epileptic GABA A receptors
Roseti, C., Martinello, K., Fucile, S., Piccari, V., Mascia, A., Gennaro, G. D., Quarato, P. P., Manfredi, M., Esposito, V., Cantore, G. P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807277105 · Cited by 55
Fernandes, C., Pinto‐Duarte, A., Ribeiro, J. A., & Sebastião, A. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5378-07.2008 · Cited by 54
Self-citationJarvis, M. F., Yu, H., McGaraughty, S., Wismer, C. T., Mikusa, J. P., Zhu, C., Chu, K. L., Kohlhaas, K. L., Cowart, M., Lee, C., et al. (2002) · Pain · doi:10.1016/s0304-3959(01)00435-3 · Cited by 54
Magalhães-Cardoso, M. T., Pereira, M. F., Oliveira, L., Ribeiro, J. A., Cunha, R. A., & Correia‐de‐Sá, P. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.040410 · Cited by 54
Self-citationZhang, C., & Schmidt, J. T. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.2947 · Cited by 53
Shapiro, R. E. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0773-5 · Cited by 53
Coleman, C. G., Baghdoyan, H. A., & Lydic, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03700.x · Cited by 53
Desfrère, L., Olivier, P., Schwendimann, L., Verney, C., & Gressèns, P. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e318156e425 · Cited by 52
Dopaminergic Mechanism for Caffeine-Produced Cocaine Seeking in Rats
Green, T. A., & Schenk, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00343-8 · Cited by 52
Weerts, E. M., & Griffiths, R. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1410-5 · Cited by 51
Batista, L. C., Prediger, R. D., Morato, G. S., & Takahashi, R. N. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0014-7 · Cited by 51
Poon, A., & Sawynok, J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00626-3 · Cited by 51
Tebano, M. T., Pintor, A., Frank, C., Domenici, M. R., Martire, A., Pepponi, R., Potenza, R. L., Grieco, R., & Popoli, P. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20138 · Cited by 51
Hohoff, C., McDonald, J. M., Baune, B. T., Cook, E. H., Deckert, J., & de Wit, H. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30228 · Cited by 50
DeLander, G. E., & Wahl, J. J. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22108-5 · Cited by 49
Ortinau, S., Laube, B., & Zimmermann, H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04996.2003 · Cited by 48
Adenosine A2A receptor mRNA expression in Parkinson's disease
Hurley, M. J., Mash, D. C., & Jenner, P. G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01371-9 · Cited by 47
Caffeine taste test for panic disorder: Adenosine receptor supersensitivity
DeMet, E. M., Stein, M. K., Tran, C., Chicz-DeMet, A., Sangdahl, C., & Nelson, J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90014-0 · Cited by 47
Cunha‐Reis, D., Sebastião, A. M., Wirkner, K., Illés, P., & Ribeiro, J. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705989 · Cited by 45
Self-citationOgata, T., Nakamura, Y., & Schubert, P. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01280.x · Cited by 45
Gomes, C. A., Vaz, S. H., Ribeiro, J. A., & Sebastião, A. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.025 · Cited by 45
Self-citationArrigoni, E., Crocker, A. J., Saper, C. B., Greene, R. W., & Scammell, T. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.009 · Cited by 45
Ganfornina, M. D., Pérez-García, M. T., Gutiérrez, G., Miguel‐Velado, E., López‐López, J. R., Marín, A., Sánchez, D., & González, C. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.088815 · Cited by 44
Budd, D. C., & Nicholls, D. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020615.x · Cited by 44
Changes in Spinal δ and κ Opioid Systems in Mice Deficient in the A2AReceptor Gene
Bailey, A., Ledent, C. A., Kelly, M., Hourani, S. M. O., & Kitchen, I. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09210.2002 · Cited by 44
Klishin, A., Tsintsadze, T. S., Lozovaya, N., & Krishtal, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12431 · Cited by 43
Congar, P., Khazipov, R., & Ben‐Ari, Y. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.73.1.421 · Cited by 43
The mGlu5 receptor agonist CHPG stimulates striatal glutamate release
Pintor, A., Pèzzola, A., Reggio, R., et al. (2000) · Neuroreport · doi:10.1097/00001756-200011090-00042 · Cited by 42
Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease
Deleu, D., Jacob, P., Chand, P., Sarre, S., & Colwell, A. (2006) · Neurology · doi:10.1212/01.wnl.0000233916.57415.9d · Cited by 42
NMDA-Independent LTP by Adenosine A2Receptor-Mediated Postsynaptic AMPA Potentiation in Hippocampus
Kessey, K., & Mogul, D. J. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.4.1965 · Cited by 42
Allosteric Adenosine Modulation to Reduce Allodynia
Pan, H., Xu, Z., Leung, E., & Eisenach, J. C. (2001) · Anesthesiology · doi:10.1097/00000542-200108000-00025 · Cited by 41
Hong, C.-J., Liu, H.-C., Liu, T.-Y., Liao, D., & Tsai, S. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0286-4 · Cited by 41
Fowler, J. C. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168775 · Cited by 40
Selley, D. E., Cassidy, M. P., Martin, B. R., & Sim‐Selley, L. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000604 · Cited by 40
Adenosine A2AReceptors are Up‐regulated in Pick’s Disease Frontal Cortex
Albasanz, J. L., Rodríguez, A., Ferrer, I., & Martín, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00026.x · Cited by 39
Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction
Sebastião, A. M., & Ribeiro, J. A. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb12051.x · Cited by 39
Self-citationYamagata, K., Hakata, K., Maeda, A., Mochizuki, C., Matsufuji, H., Chino, M., & Yamori, Y. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.08.016 · Cited by 39
Kuzmin, A. V., Johansson, B., Zvartau, E. E., & Fredholm, B. B. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34932-8 · Cited by 39
A1 adenosine receptor activation inhibits neurite process formation by rho kinase-mediated pathways
Thevananther, S., Rivera, A. L., & Rivkees, S. A. (2001) · Neuroreport · doi:10.1097/00001756-200110080-00015 · Cited by 38
Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals
Vaz, S. H., Cristóvão‐Ferreira, S., Ribeiro, J. A., & Sebastião, A. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.008 · Cited by 38
Self-citationSuppression of presynaptic responses to adenosine by activation of NMDA receptors
Nikbakht, M. R., & Stone, T. W. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01171-2 · Cited by 38
Increase in Adenosine Sensitivity in the Nucleus Accumbens Following Chronic Morphine Treatment
Brundege, J. M., & Williams, J. T. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00508.2001 · Cited by 37
Cunha‐Reis, D., Ribeiro, J. A., & Sebastião, A. M. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.077 · Cited by 37
Self-citationKaplan, G. B., & Leite‐Morris, K. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00413-7 · Cited by 37
O'Neill, C., Nolan, B. J., Macari, A., O'Boyle, K. M., & O'Connor, J. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05953.x · Cited by 37
de Mendonça, A., & Ribeiro, J. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701291 · Cited by 36
Self-citationMori, Y., Higuchi, M., Masuyama, N., & Gotoh, Y. (2004) · Cell Structure and Function · doi:10.1247/csf.29.101 · Cited by 34
Purines, the carotid body and respiration
Lahiri, S., Mitchell, C. H., Reigada, D., Roy, A., & Cherniack, N. S. (2007) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2007.02.015 · Cited by 34
Adenosine receptors in post‐mortem human brain
James, S., Xuereb, J. H., Askalan, R., & Richardson, P. J. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14240.x · Cited by 33
Calcitonin gene-related peptide (CGRP) antagonists and migraine: Is this a new era?
Goadsby, P. J. (2008) · Neurology · doi:10.1212/01.wnl.0000309214.25038.fd · Cited by 33
Basal levels of adenosine modulate mGluR5 on rat hippocampal astrocytes
Cormier, R. J., Mennerick, S. J., Melbostad, H. S., & Zorumski, C. F. (2001) · Glia · doi:10.1002/1098-1136(20010101)33:1<24::aid-glia1003>3.0.co;2-l · Cited by 33
Caffeine challenge in insomniac patients after total sleep deprivation☆
Salín-Pascual, R. J., Valencia‐Flores, M., Campos, R. R., CASTANO, A., & Shiromani, P. J. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.008 · Cited by 31
Adenosine mediates sedative action of various centrally active drugs
Phillis, J. W., & Wu, P. H. (1982) · Medical Hypotheses · doi:10.1016/0306-9877(82)90074-3 · Cited by 30
Schotanus, S. M., Fredholm, B. B., & Chergui, K. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.025 · Cited by 30
Lucchi, R., Latini, S., de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (1996) · Brain Research · doi:10.1016/0006-8993(96)00748-2 · Cited by 30
Self-citationCunha‐Reis, D., Ribeiro, J. A., & Sebastião, A. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.037 · Cited by 27
Self-citationEvoked release of endogenous adenosine from rat cortical slices by K+ and glutamate
Hoehm, K., & White, T. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)91487-x · Cited by 26
Evaluation of cognitive brain functions in caffeine users: a P3 evoked potential study.
Dixit, A., Vaney, N., & Tandon, O. P. (2006) · PubMed · Cited by 25
Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s
(1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7218-8 · Cited by 25
Martini, C., Tuscano, D., Trincavelli, M. L., Cerrai, E., Bianchi, M., Ciapparelli, A., Alessio, L., Novelli, L., Catena, M., Lucacchini, A., et al. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.12.008 · Cited by 25
Duarte‐Araújo, M., Timóteo, M. A., & Correia‐de‐Sá, P. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.027 · Cited by 25
DeSanty, K. P., & Dar, M. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02533-1 · Cited by 25
An Adenosine Analogue Inhibits NMDA Receptor-Mediated Responses in Bipolar Cells of the Rat Retina
Costenla, A. R., de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (1999) · Experimental Eye Research · doi:10.1006/exer.1998.0645 · Cited by 24
Self-citationInteractions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice
Shahraki, A. S., & Stone, T. W. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705083 · Cited by 21
Cunha‐Reis, D., Fontinha, B. M., Ribeiro, J. A., & Sebastião, A. M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.003 · Cited by 20
Self-citationUematsu, T., Kozawa, O., Matsuno, H., Niwa, M., Yoshikoshi, H., Ohuchi, M., Kohno, K., Nagashima, S., & Kanamaru, M. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00214.x · Cited by 20
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice
Listos, J., Malec, D., & Fidecka, S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.025 · Cited by 20
Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice
Bilbao, A., Cippitelli, A., Martín, A. B. B., Granado, N., Ortiz, Ó., Bézard, E., Chen, J., Navarro, M. A., de Fonseca, F. R., & Moratalla, R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0284-0 · Cited by 19
Donoso, M. V., Aedo, F., & Huidobro-Toro, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03671.x · Cited by 17
Poleszak, E., & Malec, D. (2003) · PubMed · Cited by 17
Listos, J., Talarek, S., & Fidecka, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.011 · Cited by 16
Up‐regulation of adenosine A1receptors in frontal cortex from Pick's disease cases
Albasanz, J. L., Rodríguez, A., Ferrer, I., & Martín, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05965.x · Cited by 16
The movers and shakers of deep brain stimulation
Asaad, W. F., & Eskandar, E. N. (2008) · Nature Medicine · doi:10.1038/nm0108-17 · Cited by 12
Cited by
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631
“The use of adenosine receptor antagonists, such as caffeine, has shown its usefulness not only in the treatment, but also in the protection against the aforementioned diseases [128-131].”
BackgroundPurinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Adenosine, energy metabolism and sleep homeostasis
Porkka-Heiskanen, T., & Kalinchuk, A. V. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.06.005 · Cited by 328
Adenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 310
Metadata
- Authors
- Sebastião, A. M., & Ribeiro, J. A.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2009
- Issue
- 193
- Pages
- 471-534
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2139817708
- Cited by
- 266
- References
- 331
- FWCI
- 9.87
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.